Pharmaceutical manufacturing and Pharmacoeconomics
Pharmaceutical Manufacturing is the process used by businesses that produce pharmaceutical drugs. It faces on going pressure to accelerate innovation and quicken the pace at which they bring profitable products to market. The era of large pharmaceutical firms having a large number of manufacturing facilities is slowly coming to an end, and all businesses, regardless of size, are searching for methods to cut costs in order to compete in an environment that is becoming more challenging and unstable.
At various stages of medication development and commercialization, pharmacoeconomics is examined as part of decision-making processes. Increased decision-making issues and advancements in pharmacoeconomic research methods suggest that pharmacoeconomics will play a larger role in the new millennium. The pharmaceutical industry's businesses will suffer as a result of this.
- Cost-of-illness analysis
- Cost-benefit analysis
- Budget-impact analysis
- Cost-utility analysis
Related Conference of Pharmaceutical manufacturing and Pharmacoeconomics
30th International Conference on Neuropharmacology and Neurochemistry
5th International Forum on Pharmacovigilance and Regulatory Affairs
Pharmaceutical manufacturing and Pharmacoeconomics Conference Speakers
Recommended Sessions
- Pharmaceutical manufacturing and Pharmacoeconomics
- Advanced Pharmaceutical Technology
- Bioequivalence and Bioavailability
- Clinical Pharmacy and Pharmacy Practices
- Digital Pharma and Marketing
- Drug Discovery
- Drug Discovery
- Drug Discovery, Design & Development: Challenges and Approaches
- Nano medicine and Biomedical Application
- Novel Drug Delivery Systems, Biomarkers and Drug Targets
- Pharmaceutical Analysis
- Pharmaceutical Care and Health System
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Innovation
- Pharmaceutical Microbiology
- Pharmaceutical Nanotechnology
- Pharmacogenomics and Pharmacoepidemiology
- Pharmacology and Toxicology
- Technology in Pharma Sciences
- The future of Pharma R&D
Related Journals
Are you interested in
- Artificial Intelligence in Neuropharmacological Drug Discovery - Neuropharmaceutics 2027 (Netherlands)
- Blood-Brain Barrier Pharmacology and Drug Delivery - Neuropharmaceutics 2027 (Netherlands)
- Brain-Computer Interfaces and Neurochemical Modulation - Neuropharmaceutics 2027 (Netherlands)
- Computational and Systems Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Digital Biomarkers and Neurochemical Monitoring Technologies - Neuropharmaceutics 2027 (Netherlands)
- Integrating Neurochemistry with Computational Brain Modeling - Neuropharmaceutics 2027 (Netherlands)
- Machine Learning Models in Neurochemical Data Analysis - Neuropharmaceutics 2027 (Netherlands)
- Molecular Mechanisms in Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Basis of Epilepsy and Anticonvulsant Pharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Basis of Mood Disorders and Emotional Regulation - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Big Data and Cloud-Based Pharmacology Platforms - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Biosensors and Real-Time Brain Monitoring - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Mechanisms in Neurodegenerative Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Signaling and Synaptic Transmission - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Addiction and Reward Pathways - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Neuroendocrine Regulation - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Psychiatric and Mood Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuroimaging Analytics and Computational Mapping of Brain Chemistry - Neuropharmaceutics 2027 (Netherlands)
- Neuroinflammation and Pharmacological Modulation - Neuropharmaceutics 2027 (Netherlands)
- Neuroinformatics and Computational Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacological Approaches to Pain and Analgesia - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacological Approaches to Pain Modulation and Analgesia - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Addiction and Substance Abuse - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Cognitive Function and Memory - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neurodegenerative Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neurodevelopmental and Autism Spectrum Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neuroplasticity and Neural Regeneration - Neuropharmaceutics 2027 (Netherlands)
- Neurotransmitter Receptors and Signal Transduction - Neuropharmaceutics 2027 (Netherlands)
- Precision Neuropharmacology through Artificial Intelligence and Genomic Profiling - Neuropharmaceutics 2027 (Netherlands)
- Virtual Drug Screening and Molecular Docking in Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
